Trial Profile
Efficacy and Safety of Efinaconazole 10% Solution in the Treatment of Onychomycosis in Diabetic Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Oct 2019
Price :
$35
*
At a glance
- Drugs Efinaconazole (Primary)
- Indications Onychomycosis
- Focus Therapeutic Use
- 01 Oct 2019 Status changed from active, no longer recruiting to completed.
- 03 Oct 2018 Planned End Date changed from 13 Nov 2018 to 20 Dec 2018.
- 03 Oct 2018 Planned primary completion date changed from 13 Nov 2018 to 20 Dec 2018.